Home

Search Abstracts

Browse Oral Sessions

Browse Poster Sessions

Session 64-Poster Abstracts Host Resistance to Infection and Disease Progression Wednesday, 2-4 pm; Poster Hall       289 Evolution of an Attenuated HIV-1 Isolate in an Elite Suppressor Maria Salgado*1, S Gandhi1, R Siliciano1,2, and J Blankson1 1Johns Hopkins Univ Sch of Med, Baltimore, MD, US and 2Howard Hughes Med Inst, Baltimore, MD, US       290 Proportion of HIV Elite Controllers and Loss of Elite Status According to 2 Commonly Used Definitions Ashley Olson*1, L Meyer2, M Prins3, R Thiebaut4, M Guiguet5,6, M-L Chaix7, P Amornkul8, A Babiker1, K Porter1, and CASCADE Collaboration in EuroCoord 1MRC Clin Trials Unit, London, UK; 2Svc d`Epidémiologie et de Santé Publ Hôpital de Bicêtre, Paris, France; 3Amsterdam Publ Hlth Svc, The Netherlands; 4Univ Victor Segalen, Bordeaux, France; 5INSERM U943, Paris, France; 6UMR S270, Univ Pierre and Marie Curie, Paris, France; 7Univ Paris Descartes, Hosp Necker Enfants Malades, Paris, France; and 8Intl AIDS Vaccine Initiative, San Francisco, CA, US       291 Total, Episomal, and Integrated HIV DNA Quantification from HIV Elite Controllers: Insights for Ongoing Replication and HIV Reservoir Caroline Passaes*1, F Cortes1, G Bello1, D Babic2, M Sharkey2, C Vorsatz3, B Grinsztejn3, V Veloso3, M Stevenson2, and M Morgado1 1Inst Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil; 2Univ of Miami Miller Sch of Med, FL, US; and 3Inst de Pesquisa Clin Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil       292 HIV-1 Infection in a CCR5-D32/D32, HLA-B*5701, and HLA-A*2402 Subject: A Case Report Ester Ballana*, C Pou, M Permanyer, J Santos, R Paredes, C Brander, MA Martinez, B Clotet, and J Este Fndn irsiCaixa, Hosp Univ Germans Trias i Pujol, Univ Autònoma de Barcelona, Spain       293 Elevated p21/WAF1 RNA Expression Is Associated with Resistance to HIV Infection J Herbeck1, Suvankar Ghorai*1, L Chen1, C Rinaldo2, L Jacobson3, R Detels4, S Wolinsky5, J Margolick3, and J Mullins1 1Univ of Washington, Seattle, US; 2Univ of Pittsburgh, PA, US; 3Johns Hopkins Univ, Baltimore, MD, US; 4Univ of California, Los Angeles, US; and 5Northwestern Univ, Chicago, IL, US       294 Investigation of Associations between Human Genetic Variation and Resistance to HIV-1 Infection in Highly Exposed Uninfected Individuals with Hemophilia A Jérôme Lane*1, L Dorrell2, K Pelak3, M Carrington4, J Goedert5, B Haynes3, A McMichael2, K Shianna3, D Goldstein3, J Fellay1, and NIAID Ctr for HIV/AIDS Vaccine Immunology 1École Polytechnique Fédérale de Lausanne, Switzerland; 2Univ of Oxford, UK; 3Duke Univ, Durham, NC, US; 4NCI-Frederick, MD, US; and 5NCI, NIH, Bethesda, MD, US       295 Joining Forces in HIV Host Genomics: The International HIV Acquisition Consortium Paul McLaren*1, J-F Zagury2, J Fellay3, and the Intl HIV Acquisition Consortium 1Brigham and Women`s Hosp and Broad Inst of MIT and Harvard, Boston, MA, US; 2Conservatoire Natl des Arts et Métiers, Paris, France; and 3Federal Inst of Tech, Lausanne, Switzerland       296 Proteomics of HIV-1 Control Ming Li*, M Lally, and B Ramratnam Warren Alpert Med Sch, Brown Univ, Providence, RI, US       297 Differences in Cytokine Levels in HIV-1+ Individuals Might Contribute to Natural Control of HIV Infection by Viremic Non-progressors Judith Dalmau*1, I Erkizia1, M Rotger2, A Rauch3, M Massanella1, E Palou4, B Clotet1, J Blanco1, A Telenti2, and J Martinez-Picado1,5 1AIDS Res Inst, Fndn irsiCaixa, Badalona, Spain; 2Univ de Lausanne, Switzerland; 3Universitätsklinik für Infektiologie, Bern, Switzerland; 4Banc de Sang i Teixits, Barcelona, Spain; and 5Inst Catalana de Recerca i Estudis Avançats, Barcelona, Spain       298 The Effect of TRIM5 Allelic Polymorphisms on Primary SIV/DeltaB670 Infections in Rhesus Macaques Angela Amedee*1, H Michael2, N Lacour1, H Aamer2, and M Murphey-Corb2 1Louisiana State Univ Hlth Sci Ctr, New Orleans, US and 2Univ of Pittsburgh Sch of Med, PA, US